Group Leader

    Otto Kauko, M.D., Ph.D.
    otkauko [at]

    Contact Information

    Cancer Proteomics
    Turku Bioscience
    University of Turku
    P.O. Box 123
    Tykistökatu 6A
    FIN-20521 Turku, Finland

    We study the essential outcomes of cancer cell signaling by utilizing a range of proteomics, single-cell omics, and genome editing techniques. Current projects focus on the regulation of rRNA synthesis, proteogenomic analyses of head and neck cancers, targeted therapy resistance in melanoma, and acid-labile phosphorylation.

    Our group operates in Turku Proteomics facility. More information about the people and the mass spec laboratory can be found here: Turku Proteomics Facility

    Selected Publications

    Kauko et al. BioRxiv. BioRxiv

    Pihlajamaa, Kauko et al. Nat Biotechnol 2022. PubMed

    Kauko et al. J Biol Chem 2020. PubMed

    Kauko et al. Sci Transl Med 2018. PubMed